The risks of liver injury in COVID-19 patients and pharmacological management to reduce or prevent the damage induced

BACKGROUND: The global pandemic COVID-19 caused by the new coronavirus SARS-CoV-2 has already caused about 1.4 million deaths, and to date, there are no effective or direct antiviral vaccines. Some vaccines are in the last stages of testing. Overall mortality rates vary between countries, for exampl...

Descripción completa

Detalles Bibliográficos
Autores principales: Vitiello, Antonio, La Porta, Raffaele, D’Aiuto, Vilma, Ferrara, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7838235/
https://www.ncbi.nlm.nih.gov/pubmed/34777865
http://dx.doi.org/10.1186/s43066-021-00082-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7838235/
https://www.ncbi.nlm.nih.gov/pubmed/34777865
http://dx.doi.org/10.1186/s43066-021-00082-y

Ejemplares similares